“Real-World Switch Rates of Risankizumab and Other Biologics in Psoriasis Patients With Psoriatic Arthritis”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s443, https://doi.org/10.25251/skin.8.supp.443.